Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system-Reference-Cited by-同舟云学术

Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system

Published:2001-12 Issue:4 Volume:115 Page:983-990
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Albertsen Birgitte Klug,Schrøder Henrik,Ingerslev Jørgen,Jakobsen Preben,Avramis Vassilios I.,Müller Hans-Joachim,Carlsen Niels T.,Schmiegelow Kjeld

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.03148.x/fullpdf

Reference30 articles.

1. Dose reduction of asparaginase under pharmacokinetic and pharmacodynamic control during induction therapy in children with acute lymphoblastic leukaemia;Ahlke;British Journal of Haematology,1997

2. Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukemia;Andrew;Blood Coagulation and Fibrinolysis,1994

3. The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia;Asselin;Advances in Experimental Medicine and Biology,1999

4. Comparative pharmacokinetic studies of three asparaginase preparations;Asselin;Journal of Clinical Oncology,1993

5. Pharmacokinetics and drug monitoring of l-asparaginase treatment. International;Boos;Journal of Clinical Pharmacology and Therapeutics,1997

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Back to the future: the amazing journey of the therapeutic antileukemia enzyme asparaginase <i>Erwinia chrysanthemi</i>;Haematologica;2023-07-20

2. Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing;British Journal of Clinical Pharmacology;2022-09-11

3. Depletion of d ‐ and l ‐asparagine in cerebrospinal fluid in acute lymphoblastic leukemia during PEGasparaginase therapy;Pediatric Blood & Cancer;2022-07-26

4. Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma;Frontiers in Pediatrics;2022-06-30

5. Asparaginase encapsulated in erythrocytes as second‐line treatment in hypersensitive patients with acute lymphoblastic leukaemia;British Journal of Haematology;2022-03-28